Not intended for U.S. and UK Media - EASD Congress 2022:
Bayer to present new cardiorenal data for Kerendia™ (finerenone) across a broad range of patients with early to late-stage chronic kidney disease and type 2 diabetes
Not intended for U.S. and UK Media – ESMO Congress 2022
New ARASENS data reinforce strong tolerability profile of darolutamide plus ADT and docetaxel without compromising quality of life for patients with mHSPC
